-
New UK competition rules to affect global deal reviews for tech and pharma
The pharma industry has been the focus of recent competition investigations in the UK, EU and US.
-
Microsoft hits out at CMA investigation into UK cloud services
The US tech giant has called the regulator’s latest move “a step in the wrong direction.”
-
CMA head says regulator will interfere in fewer global deals in the future
UK regulators are under increasing pressure from the government to cut red tape and prioritise economic growth.
-
CMA receives offer from Vifor Pharma
If the offer is accepted, Vifor Pharma’s commitments will become legally binding and the CMA will not have to determine if the law was broken.
-
CMA reaches settlement with four banks in sensitive information sharing case
Four of the banks that were being investigated have agreed to pay fines totalling more than $132m collectively.
-
UK regulators could face government audit as push for economic growth continues
But critics argue too much government intervention could weaken the UK’s strong independent regulatory sector.
-
CMA chief calls for constructive engagement with US tech giants
Chief executive stresses “fines are a last resort.”
-
No trade-off between financial stability and economic growth, BoE governor tells MPs
Andrew Bailey backs drive for growth but says moves already being made to ease regulatory burden.